As of 2025-12-11, the Intrinsic Value of Pharmadrug Inc (PHRX.CN) is -0.02 CAD. This PHRX.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Pharmadrug Inc is -180.80%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Pharmadrug Inc (PHRX.CN) is overvalued by 180.80%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.02 - -0.02 | -0.02 | -180.80% |
| DDM - Stable | (0.20) - 0.29 | 0.05 | 126.6% |
| DDM - Multi | (8.47) - 9.30 | (150.41) | -752153.0% |
| Market Cap (mil) | 1.57 |
| Beta | -0.78 |
| Outstanding shares (mil) | 78.42 |
| Enterprise Value (mil) | 2.98 |
| Market risk premium | 5.10% |
| Cost of Equity | 3.58% |
| Cost of Debt | 5.00% |
| WACC | 4.09% |